Portal de Periódicos da CAPES

The Use of Dapsone in the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica

1983; Wiley; Volume: 26; Issue: 5 Linguagem: Inglês

10.1002/art.1780260521

1529-0131

P Doury, S Pattin, F Eulry, A Thabaut,

Coagulation, Bradykinin, Polyphosphates, and Angioedema

Arthritis & RheumatismVolume 26, Issue 5 p. 689-690 LetterFree to Read The Use of Dapsone in the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica P. Doury MD, P. Doury MD Hǒpital d'Instruction des Armées Bégin St. Mande, FranceSearch for more papers by this authorS. Pattin MD, S. Pattin MD Hǒpital d'Instruction des Armées Bégin St. Mande, FranceSearch for more papers by this authorF. Eulry MD, F. Eulry MD Hǒpital d'Instruction des Armées Bégin St. Mande, FranceSearch for more papers by this authorA. Thabaut MD, A. Thabaut MD Hǒpital d'Instruction des Armées Bégin St. Mande, FranceSearch for more papers by this author P. Doury MD, P. Doury MD Hǒpital d'Instruction des Armées Bégin St. Mande, FranceSearch for more papers by this authorS. Pattin MD, S. Pattin MD Hǒpital d'Instruction des Armées Bégin St. Mande, FranceSearch for more papers by this authorF. Eulry MD, F. Eulry MD Hǒpital d'Instruction des Armées Bégin St. Mande, FranceSearch for more papers by this authorA. Thabaut MD, A. Thabaut MD Hǒpital d'Instruction des Armées Bégin St. Mande, FranceSearch for more papers by this author First published: May 1983 https://doi.org/10.1002/art.1780260521Citations: 21AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Graisely B, Audebert AA, Offret H, de Saint Maur PP: Evolutivité de la maladie de Horton sous corticothérapie. Nouv Presse Med 9: 2736, 1980 2 Barranco VP, Minor DB, Solomon H: Treatment of relapsing polychondritis with dapsone. Arch Dermatol 112: 1286–1288, 1976 3 Deschamps P, Leroy D, Mandard JC, Benard Y: Traitement de la polychondrite chronique atrophiante par les sulfones: une observation. Nouv Presse Med 7: 2549–2552, 1978 4 Liot F, Lemaigre D, Dessanges JF, Leroy M: Polychondrite chronique atrophiante avec atteinte respiratoire prédominante: traitement par les sulfones: intérět de l'exploration fonctionnelle. Ann Med Interne 131: 519–524, 1980 5 Bonnetblanc JM, Adenis JP, Querol M, Rammaert B, and Collaborative Study Group: Immunofluorescence in temporal arteritis. N Engl J Med 298: 458, 1978 6 Bonnetblanc JM, Gualde N, Liozon F, Catanzano G, et Groupe d'Etudes de Limoges: Etude en immunofluorescence de l'artérite temporale, 2ème Séance de Recherche Dermatologique, Crétell, November 22–23, 1980 7 Bonnetblanc JM, Vidal E, Hessel L, Michel JP, Liozon F: Traitement adjuvant dans la maladie de Horton. Nouv Presse Med 10: 2020–2121, 1981 Citing Literature Volume26, Issue5May 1983Pages 689-690 ReferencesRelatedInformation